Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

Publication date

2015-08

Authors

Groenendijk, Floris H
Fransen van de Putte, Elisabeth E
van Rhijn, Bas W G
Bernards, RISNI 0000000392776801
van der Heijden, Michiel S

Editors

Advisors

Supervisors

Document Type

Comment

Collections

Open Access logo

License

taverne

Abstract

Keywords

Taverne, Comment, Letter

Citation

Groenendijk, F H, Fransen van de Putte, E E, van Rhijn, B W G, Bernards, R & van der Heijden, M S 2015, 'Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re : Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014', European Urology, vol. 68, no. 2, pp. e33-4. https://doi.org/10.1016/j.eururo.2015.02.043